Common medications equally effective at controlling high blood pressureNovember 14th, 2007 - 8:25 am ICT by admin
Authors of the report also said that more research is needed to learn how ACEIs and ARBs may differ when it comes to longer-term benefits and harms.
The AHRQ-funded study, completed by the Agency’s Duke University Evidence-based Practice Center in Durham, N.C., compared both the benefits and harms of ACEIs and ARBs. Both classes of drugs control blood pressure effectively by targeting a key hormone that helps regulate blood pressure. The AHRQ-funded study did not include other blood pressure treatments such as diuretics or beta blockers.
The reports revealed that ACEIs and ARBs are equally effective at controlling blood pressure.
ACEIs are slightly more likely to ARBs causing a harmless but persistent and dry cough. In studies of patients in everyday clinical settings, a dry cough was reported by about 1.7 percent of patients who took ACEIs and about 0.6 percent who took ARBs. Patients who took ACEIs in clinical trials were slightly more likely than patients who took ARBs to withdraw from the studies.
They also found that there are no consistently apparent differences between ACEIs and ARBs when it comes to impacting blood fats known as lipids, managing or slowing the progression of diabetes, controlling renal disease, or impacting heart function.
The scientists also revealed the urgency of more research being conducted to compare the drugs’ benefits and harms for hypertension patients who have additional health problems, such as diabetes, congestive heart failure, chronic kidney disease, and dyslipidemia (an imbalance in lipid/cholesterol metabolism). Future studies should include more patients who are older and from ethnic and racial minorities.
“An enormous number of Americans have high blood pressure, and we need to provide them with the best information possible about their medications’ potential benefits and harms,” said the Agency for Healthcare Research and Quality, Director Carolyn M. Clancy, M.D.
“This report summarizes the current scientific evidence on these medications and helps set the agenda for needed research,” he added.
The summary of the study was published on-line in the Annals of Internal Medicine. (ANI)
- BP drug could harm stroke patients - Feb 13, 2011
- Why hypertensive people's BP increases during exercise - Apr 05, 2011
- Combination ACE inhibitor therapy raises risk of kidney failure, death - Mar 22, 2011
- Blood pressure medications show higher cancer risk: Study - Jun 14, 2010
- Study links Blood pressure drugs to cancer - Jun 15, 2010
- BP drug not tied to death risk among heart patients - Apr 11, 2012
- Singing lowers patient's BP prior to surgery - Mar 31, 2011
- Three-pill combo for high BP launched - Nov 22, 2011
- Blood Pressure Drugs Increase Cancer Risk, Study Reveals - Jun 15, 2010
- Anti-hypertensive drug improves multiple sclerosis-related brain inflammation - Jul 29, 2010
- Further evidence on benefits of BP drugs in diabetic retinopathy treatment - Feb 25, 2010
- Common Blood Pressure Drugs May Amplify The Risk Of Cancer - Jun 15, 2010
- BP drugs may cut dementia risk - Jan 13, 2010
- Patients receiving dialysis 'at higher risk for sudden cardiac death' - Nov 15, 2010
- 'Water pills' just as effective as costly BP drugs: Study - Aug 13, 2010
Tags: ahrq, annals of internal medicine, apparent differences, arbs, beta blockers, blood fats, cholesterol metabolism, chronic kidney disease, classes of drugs, congestive heart failure, control blood pressure, controlling high blood pressure, diabetes, diuretics, drugs control, duke university, dyslipidemia, heart function, hypertension patients, persistent dry cough